Top Markets
#1 Helium Helium +109.41%
#2 MowCat MowCat +103.90%
#3 Seeker Seeker +74.55%
#4 Pons Pons +47.43%
#5 AI XOVIA AI XOVIA +39.39%
#6 UnifAI Network UnifAI Network +33.34%
#7 Bounce Bounce +30.38%
#8 Tensor Tensor +22.88%
#9 Zylo Ecosystem Zylo Ecosystem +21.26%
#10 pipedog pipedog +20.42%
Coin of the day
Helium Helium
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Rang in Aktien #11443
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Aktienkurs
$8.74
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$699.74M
Veränderung (1 Tag)
-4.85%
Veränderung (1 Jahr)
-2.29%
Land
US
Handel BridgeBio Oncology Therapeutics Inc. (BBOT)

Kategorie

Healthcare
Dividendenrendite-Verlauf für BridgeBio Oncology Therapeutics Inc. (BBOT)
Dividendenrendite (TTM) von BridgeBio Oncology Therapeutics Inc. (Aktienkürzel: BBOT) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für BridgeBio Oncology Therapeutics Inc. (BBOT) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH